Holen Sie sich die Stockscreener-App
4.36
0.93%
0.04
Handel nachbörslich:
4.27
-0.09
-2.06%
Schlusskurs vom Vortag:
$4.32
Offen:
$4.37
24-Stunden-Volumen:
1.13M
Relative Volume:
0.97
Marktkapitalisierung:
$261.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-40.33M
KGV:
-2.4358
EPS:
-1.79
Netto-Cashflow:
$-39.53M
1W Leistung:
+13.84%
1M Leistung:
+53.52%
6M Leistung:
+31.72%
1J Leistung:
-17.74%
1-Tages-Spanne:
$4.13
$4.60
1-Wochen-Bereich:
$3.67
$4.60
52-Wochen-Spanne:
$2.315
$5.44
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
Firmenname
Eledon Pharmaceuticals Inc
Sektor
Branche
Telefon
949-238-8090
Adresse
19800 MACARTHUR BLVD., IRVINE
Vergleichen Sie ELDN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELDN
Eledon Pharmaceuticals Inc
|
4.36 | 258.69M | 0 | -40.33M | -39.53M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Guggenheim | Buy |
| 2022-05-13 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-03-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc Aktie (ELDN) Neueste Nachrichten
How Eledon Pharmaceuticals Inc. (2TK) stock valuation compares with sector2025 Market WrapUp & Safe Entry Point Identification - newser.com
Published on: 2025-11-03 08:17:43 - newser.com
Market reaction to Eledon Pharmaceuticals Inc.’s recent news2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
Is Eledon Pharmaceuticals Inc. (2TK) stock attractive post correctionSwing Trade & Risk Managed Investment Strategies - newser.com
Using AI based signals to follow Eledon Pharmaceuticals Inc.Weekly Investment Report & Verified Short-Term Trading Plans - newser.com
Will Eledon Pharmaceuticals Inc. (2TK) stock beat revenue estimates2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
Real time scanner hits for Eledon Pharmaceuticals Inc. explainedJuly 2025 Macro Moves & Daily Growth Stock Tips - newser.com
Eledon Pharmaceuticals Inc. stock momentum explained2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Visual trend scoring systems applied to Eledon Pharmaceuticals Inc.Weekly Trade Recap & Entry Point Confirmation Alerts - newser.com
Can Eledon Pharmaceuticals Inc. recover in the next quarterProfit Target & Verified Stock Trade Ideas - newser.com
Why Eledon Pharmaceuticals Inc. (2TK) stock stays on buy listsTrade Volume Report & Short-Term High Return Ideas - newser.com
Why Eledon Pharmaceuticals Inc. (2TK) stock could be top winnerDay Trade & Capital Protection Trade Alerts - newser.com
Will Eledon Pharmaceuticals Inc. stock gain from lower inflationEarnings Risk Summary & Weekly Top Gainers Alerts - newser.com
Why analysts remain bullish on Eledon Pharmaceuticals Inc. stockCPI Data & Daily Profit Maximizing Tips - newser.com
Eledon Pharmaceuticals Inc. stock daily chart insights2025 Market Sentiment & Consistent Income Trade Ideas - newser.com
Can Eledon Pharmaceuticals Inc. (2TK) stock double in coming yearsGap Down & Long-Term Investment Growth Plans - newser.com
Is Eledon Pharmaceuticals Inc. (2TK) stock supported by strong fundamentalsBull Run & Target Return Focused Stock Picks - newser.com
What dividend safety rating applies to Eledon Pharmaceuticals Inc. (2TK) stockMarket Volume Summary & Community Consensus Stock Picks - newser.com
Will breakout in Eledon Pharmaceuticals Inc. lead to full recoveryJuly 2025 Rallies & Real-Time Volume Spike Alerts - newser.com
Is Eledon Pharmaceuticals Inc. stock a buy in volatile marketsJuly 2025 Short Interest & High Conviction Trade Alerts - newser.com
Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Declines By 47.4% - MarketBeat
Published on: 2025-11-01 03:53:10 - newser.com
Published on: 2025-10-31 05:05:04 - newser.com
Is this a good reentry point in Eledon Pharmaceuticals Inc.2025 Dividend Review & Free Accurate Trade Setup Notifications - newser.com
Eledon Pharmaceuticals’ AT 1501: A Promising Kidney Transplant Study Update - TipRanks
Published on: 2025-10-31 03:44:59 - newser.com
Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):